Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Tumour cell survival signalling by the ERK1/2 pathway
Several advances in recent years have focused increasing attention on the role of the RAF-
MEK-ERK1/2 pathway in promoting cell survival. The demonstration that BRAF is a human …
MEK-ERK1/2 pathway in promoting cell survival. The demonstration that BRAF is a human …
Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?
WCG Van Staveren, DYW Solís, A Hebrant… - … et Biophysica Acta (BBA …, 2009 - Elsevier
Established human cancer cell lines are routinely used as experimental models for human
cancers. Their validity for such use is analyzed and discussed, with particular focus on …
cancers. Their validity for such use is analyzed and discussed, with particular focus on …
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification
RE Schweppe, JP Klopper, C Korch… - The Journal of …, 2008 - academic.oup.com
Context: Cell lines derived from human cancers provide critical tools to study disease
mechanisms and develop novel therapies. Recent reports indicate that up to 36% of cell …
mechanisms and develop novel therapies. Recent reports indicate that up to 36% of cell …
[HTML][HTML] Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development
It is established that tumor cell-derived VEGF acts on endothelial cells to promote
angiogenesis and tumor growth. Here, we demonstrate that in K5-SOS-dependent mouse …
angiogenesis and tumor growth. Here, we demonstrate that in K5-SOS-dependent mouse …
Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice
AT Franco, R Malaguarnera… - Proceedings of the …, 2011 - National Acad Sciences
Mutations of BRAF are found in∼ 45% of papillary thyroid cancers and are enriched in
tumors with more aggressive properties. We developed mice with a thyroid-specific knock-in …
tumors with more aggressive properties. We developed mice with a thyroid-specific knock-in …
Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
D Viola, L Valerio, E Molinaro, L Agate… - Endocrine-related …, 2016 - erc.bioscientifica.com
Thyroid cancer is rare, but it is the most frequent endocrine malignancy. Its prognosis is
generally favorable, especially in cases of well-differentiated thyroid cancers (DTCs), such …
generally favorable, especially in cases of well-differentiated thyroid cancers (DTCs), such …
Thyroid cancer cell lines: an overview
M Saiselet, S Floor, M Tarabichi, G Dom… - Frontiers in …, 2012 - frontiersin.org
Human thyroid cancer cell lines are the most used models for thyroid cancer studies. They
must be used with detailed knowledge of their characteristics. These in vitro cell lines …
must be used with detailed knowledge of their characteristics. These in vitro cell lines …
Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas
Pilocytic astrocytoma (PA) is the most common glioma in the pediatric population. PAs can
exhibit variable behavior that does not always correlate with location. Although oncogenic …
exhibit variable behavior that does not always correlate with location. Although oncogenic …
Evolving approaches to patients with advanced differentiated thyroid cancer
BR Haugen, SI Sherman - Endocrine reviews, 2013 - academic.oup.com
Advanced differentiated thyroid cancer (DTC), defined by clinical characteristics including
gross extrathyroidal invasion, distant metastases, radioiodine (RAI) resistance, and avidity …
gross extrathyroidal invasion, distant metastases, radioiodine (RAI) resistance, and avidity …
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors
Abstract Approximately, 10% to 15% of serous ovarian tumors fall into the category
designated as tumors of low malignant potential (LMP). Like their invasive counterparts …
designated as tumors of low malignant potential (LMP). Like their invasive counterparts …